Gensight Biologics SA (SIGHT) — Working Capital to Net Assets Ratio
Gensight Biologics SA (SIGHT) has a Working Capital to Net Assets ratio of 71.3% as of June 2025. Working capital of €-22.91 Million (current assets of €2.71 Million minus current liabilities of €25.62 Million) is measured against net assets of €-32.11 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Gensight Biologics SA net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Gensight Biologics SA Working Capital to Net Assets (2012–2024)
This chart shows how Gensight Biologics SA's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of June 2025, the ratio stands at 71.3%, reflecting working capital of €-22.91 Million against net assets of €-32.11 Million EUR. Check SIGHT tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Gensight Biologics SA (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Gensight Biologics SA from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Gensight Biologics SA stock valuation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 64.2% | €-17.27 Million | €-26.92 Million | €5.34 Million | €22.62 Million | ▲ +3.1 pp |
| 2023 | 61.1% | €-18.76 Million | €-30.70 Million | €6.53 Million | €25.29 Million | ▲ +115.5 pp |
| 2022 | -54.4% | €8.30 Million | €-15.28 Million | €22.95 Million | €14.64 Million | ▼ -249.0 pp |
| 2021 | 194.6% | €31.12 Million | €15.99 Million | €53.36 Million | €22.24 Million | ▼ -33.7 pp |
| 2020 | 228.3% | €26.64 Million | €11.67 Million | €43.76 Million | €17.12 Million | ▲ +81.4 pp |
| 2019 | 146.9% | €17.26 Million | €11.75 Million | €27.77 Million | €10.51 Million | ▲ +40.2 pp |
| 2018 | 106.8% | €25.48 Million | €23.87 Million | €35.08 Million | €9.60 Million | ▲ +3.6 pp |
| 2017 | 103.1% | €56.72 Million | €55.00 Million | €60.81 Million | €4.09 Million | ▼ -0.3 pp |
| 2016 | 103.4% | €55.17 Million | €53.34 Million | €58.07 Million | €2.89 Million | ▲ +5.2 pp |
| 2015 | 98.3% | €28.82 Million | €29.33 Million | €35.11 Million | €6.29 Million | ▼ -2.9 pp |
| 2014 | 101.2% | €10.70 Million | €10.58 Million | €14.27 Million | €3.56 Million | ▲ +4.7 pp |
| 2013 | 96.4% | €16.36 Million | €16.97 Million | €18.26 Million | €1.90 Million | ▼ -13.9 pp |
| 2012 | 110.4% | €-73.35K | €-66.47K | €53.73K | €127.08K | — |